AIDX 20/20 Biolabs, Inc.
Company Analysis
Latest News
🟢 20/20 Biolabs is trading 6.11% up in after-hours trading; no confirmed company-specific announcement
20/20 Biolabs is trading 6.11% higher after hours at $0.37, compared with its regular-session close of $0.35; no confirmed company-specific announcement...
🟢 20/20 Biolabs is trading 6.37% up in pre-market; no confirmed company-specific catalyst identified
20/20 Biolabs is trading at $0.37, up 6.37% in pre-market on October 6, 2026; no confirmed company-specific catalyst was identified. - Prior close: $0.35. -...
🔴 20/20 Biolabs is trading 10.1% down with no confirmed catalyst
20/20 Biolabs is trading 10.1% lower at $0.34, with no confirmed company-specific catalyst for the October 5, 2026 decline. - The company’s latest announcement...
🔴 20/20 Biolabs is trading 6% down with no confirmed catalyst
20/20 Biolabs is trading 6.29% down at $0.36, with no confirmed company-specific catalyst for the October 5 decline. - On October 2, the company announced its...
🟢 20/20 Biolabs is trading 5% up — no confirmed company-specific catalyst
20/20 Biolabs is trading 5.26% higher at $0.40, up from its October 2 close of $0.38; no company-specific catalyst is confirmed. - An October 2 announcement...
🟢 20/20 Biolabs is trading 7.3% up in pre-market with no confirmed catalyst identified
20/20 Biolabs is trading 7.29% up at $0.41, versus the October 2 close of $0.38, with no confirmed company-specific catalyst identified for the pre-market...
🔴 20/20 Biolabs is trading 5.6% down with no confirmed catalyst identified
20/20 Biolabs is trading 5.6% lower at $0.39; no confirmed company-specific catalyst for the decline was identified. - The company announced October 2 that...
🟢 20/20 Biolabs is trading 5% up in pre-market with no confirmed catalyst
20/20 Biolabs is trading 5.09% higher at $0.43 in pre-market, with no confirmed company-specific catalyst identified for the October 2 move. - The latest...
🔴 20/20 Biolabs is trading 6.05% down — no confirmed company-specific catalyst
20/20 Biolabs is trading 6.05% down at $0.41, with no confirmed company-specific catalyst explaining the October 1, 2026 decline. - The company recently...
🟢 20/20 Biolabs is trading 13.66% up — no confirmed catalyst identified
20/20 Biolabs is trading 13.66% up at $0.47, with no confirmed company-specific catalyst or direct explanation identified for the September 30 move. - On...
🟢 20/20 Biolabs is trading 7.94% up
20/20 Biolabs is trading at $0.44, up 7.94%, with no confirmed company-specific catalyst identified. - No company-specific announcement explaining the...
🟢 20/20 Biolabs is trading 12.44% up
20/20 Biolabs is trading 12.44% up at $0.46; the report does not link the move to the company’s announcement. - On September 29, 2026, the company announced...
🔴 20/20 Biolabs is trading 5.66% down — no same-day company catalyst identified
20/20 Biolabs is trading at $0.41, down 5.66%, with no fresh company-specific announcement identified to explain the September 28 decline. - Available news...
🔴 20/20 Biolabs is trading 5.45% down in after-hours trading with no confirmed company-specific catalyst
20/20 Biolabs is trading 5.45% down at $0.41 after-hours, with no confirmed company-specific announcement identified as a catalyst. - The decline followed the...
🟢 20/20 Biolabs is trading 11.06% up today — no confirmed company-specific catalyst
20/20 Biolabs is trading 11.06% higher at $0.47, with no confirmed company-specific catalyst identified. - No reliable company-specific announcement dated...
🔴 20/20 Biolabs is trading 6.22% down today as yields and inflation pressure biotech
20/20 Biolabs is trading 6.22% down now at $0.40, with the move appearing primarily sector-driven amid broader biotech weakness. - The decline extends the...
🔴 20/20 Biolabs is trading 14.69% down today as broader markets weaken
20/20 Biolabs is trading 14.69% lower at $0.40, with the decline appearing primarily linked to broad risk-off pressure and company-specific trading...
🔴 20/20 Biolabs is trading 6% down today with no identified company-specific catalyst
20/20 Biolabs is trading at $0.44, down -6.14%, with no fresh company-specific announcement identified to explain the September 23 decline. - This compares...
🟢 20/20 Biolabs is trading 6.42% up today amid a biotech-sector rally
20/20 Biolabs is trading 6.42% up at $0.50 as biotechnology stocks rally on broader sector optimism. - The sector is benefiting from a major AI drug-discovery...
20/20 Biolabs Just Handed Itself a Tenfold Share-Printing License — Can a $7 Million Company Grow Into It, or Will Dilution Swallow Investors?
Shares of 20/20 Biolabs (AIDX) jumped 9.6% to $0.51 after the company disclosed that shareholders voted to increase authorized common stock from 50 million to...